Matches in Wikidata for { <http://www.wikidata.org/entity/Q90507379> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q90507379 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90507379 description "im September 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90507379 description "scientific article published on 27 September 2019" @default.
- Q90507379 description "wetenschappelijk artikel" @default.
- Q90507379 description "наукова стаття, опублікована 27 вересня 2019" @default.
- Q90507379 name "Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study" @default.
- Q90507379 name "Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study" @default.
- Q90507379 type Item @default.
- Q90507379 label "Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study" @default.
- Q90507379 label "Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study" @default.
- Q90507379 prefLabel "Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study" @default.
- Q90507379 prefLabel "Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study" @default.
- Q90507379 P1433 Q90507379-C5333A01-5615-4F77-8E49-553EDB8B3155 @default.
- Q90507379 P1476 Q90507379-5070A38B-E134-41FF-96B6-A2FD220973CE @default.
- Q90507379 P2093 Q90507379-14A9099E-A502-458D-9CCD-6D8EC4C2B008 @default.
- Q90507379 P2093 Q90507379-31182C1B-468E-45B2-AD11-14732BAFB284 @default.
- Q90507379 P2093 Q90507379-4F00F8A5-9614-4FF7-A3A5-780E5427FD17 @default.
- Q90507379 P2093 Q90507379-7FF31772-411B-4E9D-B953-AB25CF411A86 @default.
- Q90507379 P2093 Q90507379-D943D376-FC46-49A6-BCDE-9F7C3DECF8E6 @default.
- Q90507379 P304 Q90507379-238D1315-46C6-493A-8676-CC7442C22FFB @default.
- Q90507379 P31 Q90507379-921E1444-366F-45D3-81C2-9119AB8EAC21 @default.
- Q90507379 P356 Q90507379-B73EE274-BEBD-4609-8780-4A24FC900264 @default.
- Q90507379 P478 Q90507379-34981B8B-358A-41C4-B6C5-C510EFFD86F4 @default.
- Q90507379 P577 Q90507379-FEB834AB-0C9B-418B-B5CF-99FAE76BAE9C @default.
- Q90507379 P698 Q90507379-D40847B3-810A-4440-B2D8-46AEEFFE8F18 @default.
- Q90507379 P921 Q90507379-A50906ED-EBED-4C93-95D5-CBBA09C160DA @default.
- Q90507379 P356 J.MSARD.2019.101419 @default.
- Q90507379 P698 31586800 @default.
- Q90507379 P1433 Q26842267 @default.
- Q90507379 P1476 "Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study" @default.
- Q90507379 P2093 "Aala Darki" @default.
- Q90507379 P2093 "Abdorreza Naser Moghadasi" @default.
- Q90507379 P2093 "Fereshteh Ghadiri" @default.
- Q90507379 P2093 "Peiman Masoumi" @default.
- Q90507379 P2093 "Seyedeh Nafiseh Hashemi" @default.
- Q90507379 P304 "101419" @default.
- Q90507379 P31 Q13442814 @default.
- Q90507379 P356 "10.1016/J.MSARD.2019.101419" @default.
- Q90507379 P478 "36" @default.
- Q90507379 P577 "2019-09-27T00:00:00Z" @default.
- Q90507379 P698 "31586800" @default.
- Q90507379 P921 Q412323 @default.